Cancer Immunotherapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT05651022
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 28, 2023
Completion: Sep 30, 2027
Loading map...